Philip Scheltens, MD, PhD
Amsterdam University Medical Centers
- 4 editions
- 4 talks
- 4 recordings
2022
- Symposium, Day 2 · Chair Predicting Progression & Cognitive Decline in AD and Impact on Clinical Trial Design
- Symposium, Day 2 Incorporating Factors Associated with Rate of Progression into the Design of AD Clinical Trials
2016
- Workshop · Keynote KEYNOTE LECTURE: The Prevalence of Amyloid Positivity by Age, APOE Genotype and Cognitive Status - Implications for the Diagnosis of Alzheimer’s Disease
2014
- Workshop Conflicting Biomarkers in Clinical Practice
2013
- Symposium MRI, FDG-PET and EEG for Predicting Progression in Aging, MCI and AD
- Workshop · Discussant Open Discussion
Degrees and affiliation are current where known; the program pages show affiliations as they were each year.